Related references
Note: Only part of the references are listed.Pigment Epithelium-Derived Factor Contributes to Insulin Resistance in Obesity
Seamus Crowe et al.
CELL METABOLISM (2009)
Administration of pigment epithelium-derived factor prolongs bleeding time by suppressing plasminogen activator inhibitor-1 activity and platelet aggregation in rats
S. Yamagishi et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2009)
Obesity and diabetes: lipids, 'nowhere to run to'
Margaret J. Hill et al.
CLINICAL SCIENCE (2009)
Atheroprotective Properties of Pigment Epithelium-Derived Factor (PEDF) in Cardiometabolic Disorders
Sho-ichi Yamagishi et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Angiogenesis as Risk Factor for Plaque Vulnerability
Rossella Di Stefano et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs)
Sho-Ichi Yamagishi et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2009)
Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes
Kazuo Nakamura et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2009)
Ethanol Exposure Depletes Hepatic Pigment Epithelium-Derived Factor, a Novel Lipid Regulator
Chuhan Chung et al.
GASTROENTEROLOGY (2009)
Serum level of pigment epithelium derived factor (PEDF) is an independent determinant of resting heart rate in Japanese subjects
Kazuo Nakamura et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2009)
Laminin Receptor Involvement in the Anti-angiogenic Activity of Pigment Epithelium-derived Factor
Adrien Bernard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss
Carl J. Lavie et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Pigment epithelium-derived factor (PEDF) administration inhibits occlusive thrombus formation in rats: A possible participation of reduced intraplatelet PEDF in thrombosis of acute coronary syndromes
Katsuhiko Takenaka et al.
ATHEROSCLEROSIS (2008)
Increased serum pigment epithelium derived factor levels in Type 2 diabetes patients
Alicia Jenkins et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
The Metabolic Syndrome
Marc-Andre Cornier et al.
ENDOCRINE REVIEWS (2008)
Anti-angiogenic pigment epithelium-derived factor regulates hepatocyte triglyceride content through adipose triglyceride lipase (ATGL)
Chuhan Chung et al.
JOURNAL OF HEPATOLOGY (2008)
Pigment epithelium-derived factor induces THP-1 macrophage apoptosis and necrosis by the induction of the peroxisome proliferator-activated receptor gamma
Tsung-Chuan Ho et al.
MOLECULAR IMMUNOLOGY (2008)
Regulation of Pigment Epithelium-Derived Factor Production and Release by Retinal Glial (Muller) Cells under Hypoxia
Johannes Lange et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Inflammation in atherosclerosis: From vascular biology to biomarker discovery and risk prediction
Rene R. S. Packard et al.
CLINICAL CHEMISTRY (2008)
Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes
A. J. Jenkins et al.
DIABETIC MEDICINE (2007)
PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells
T. -C. Ho et al.
CARDIOVASCULAR RESEARCH (2007)
Activation of hypoxia-inducible factor-1 via prolyl-4 hydoxylase-2 gene silencing attenuates acute inflammatory responses in postischemic myocardium
Ramesh Natarajan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Pigment epithelium-derived factor inhibits neointimal hyperplasia after vascular injury by blocking NADPH oxidase-mediated reactive oxygen species generation
Kazuo Nakamura et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Therapeutic angiogenesis in the heart: protect and serve
Daniel Molin et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Identification of a lipase-linked cell membrane receptor for pigment epithelium-derived factor
Luigi Notari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
PEDF induces apoptosis in human endothelial cells by activating p38 MAP kinase dependent cleavage of multiple caspases
Leiling Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Molecular phylogeny of the antiangiogenic and neurotrophic serpin, pigment epithelium derived factor in vertebrates
Xuming Xu et al.
BMC GENOMICS (2006)
PEDF: a potential molecular therapeutic target with multiple anti-cancer activities
Eugene T. H. Ek et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy
Sarah X. Zhang et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2006)
Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome
Sho-ichi Yamagishi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase
G Haemmerle et al.
SCIENCE (2006)
Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1 (Withdrawn Publication. See vol. 298, 2021)
J Cai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Pigment epithelial growth factor suppresses inflammation by modulating macrophage activation
Parisa Zamiri et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells
K Takenaka et al.
LIFE SCIENCES (2005)
Cytoplasmic expression and extracellular deposition of an antiangiogenic factor, pigment epithelium-derived factor, in human atherosclerotic plaques
H Baba et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9:: Implications for downregulation in hypoxia
L Notari et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer
S Filleur et al.
CANCER RESEARCH (2005)
Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF
S Yamagishi et al.
CELL AND TISSUE RESEARCH (2005)
Fatty acids and expression of adipokines
CA Drevon
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Localization of pigment epithelium-derived factor in growing mouse bone
GMY Quan et al.
CALCIFIED TISSUE INTERNATIONAL (2005)
Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential
CJ Barnstable et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2004)
Pigment epithelium-derived factor inhibits TNF-α-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation
SI Yamagishi et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Regulation of factors controlling angiogenesis in liver development: a role for PEDF in the formation and maintenance of normal vasculature
S Sawant et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Therapeutic angiogenesis and vasculogenesis for ischemic disease - Part II: Cell-based therapies
DW Losordo et al.
CIRCULATION (2004)
Therapeutic angiogenesis and vasculogenesis for ischemic disease - Part I: Angiogenic cytokines
DW Losordo et al.
CIRCULATION (2004)
Pigment-epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization
SV Petersen et al.
BIOCHEMICAL JOURNAL (2003)
PEDF: A multifaceted neurotrophic factor
J Tombran-Tink et al.
NATURE REVIEWS NEUROSCIENCE (2003)
Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders
M Autiero et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Regulation of angiogenesis by hypoxia: role of the HIF system
CW Pugh et al.
NATURE MEDICINE (2003)
Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas
JA Doll et al.
NATURE MEDICINE (2003)
Angiogenesis in health and disease
P Carmeliet
NATURE MEDICINE (2003)
Cobalt inhibits the interaction between hypoxia-inducible factor-α and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-α
Y Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium derived factor
OV Volpert et al.
NATURE MEDICINE (2002)
CD40 signaling and plaque instability
U Schönbeck et al.
CIRCULATION RESEARCH (2001)
C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
ACR Epstein et al.
CELL (2001)
Share Paper
